Literature DB >> 20717713

CCSV-MPase, a novel procoagulant metalloproteinase from Cerastes cerastes venom: purification, biochemical characterization and protein identification.

Fatah Chérifi1, Jean-Claude Rousselle, Abdelkader Namane, Fatima Laraba-Djebari.   

Abstract

A procoagulant metalloproteinase called CCSV-MPase was purified from C. cerastes venom by successive chromatographic methods starting with gel-filtration through Sephadex G-75; ion-exchange DEAE-Cellulose A-50; affinity chromatography on Benzamidine Sepharose 6B and RP-HPLC on a C8 column. CCSV-MPase has been isolated to an extent of about tenfolds and its molecular mass was evaluated at 70 kDa by SDS-PAGE. CCSV-MPase hydrolyzes casein and fibrinogene as natural substrates. Its proteolytic activity was inhibited by EDTA and 1.10-phenanthroline, a chelators of bivalent cation metals and Zn(2+) respectively. CCSV-MPase is therefore a Zn(2+)-metalloproteinase with fibrinogenolytic but not hemorrhagic activity. It greatly decreased levels of plasmatic fibrinogen when administered to rats for 24 h. This fibrinogenase hydrolyzes the Bβ chain of human fibrinogen in vitro releasing fibrinopeptide B only. LC MS/MS analysis of tryptic fragments of CCSV-MPase demonstrated that it showed some sequence similarities with four other venom metalloproteinases. CCSV-MPase could be considered as a potential therapeutic agent as it is a non-hemorrhagic enzyme and could be useful in thrombotic diseases because of its defibrinogenation of blood.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20717713     DOI: 10.1007/s10930-010-9273-1

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  33 in total

1.  Neutralization of the hemorrhagic activity of Bothrops and Lachesis snake venoms by a monoclonal antibody against mutalysin-II.

Authors:  M I Estêvão-Costa; M S Martins; E F Sánchez; C R Diniz; C Chávez-Olórtegui
Journal:  Toxicon       Date:  2000-01       Impact factor: 3.033

Review 2.  Snake venom thrombin-like enzymes: from reptilase to now.

Authors:  H C Castro; R B Zingali; M G Albuquerque; M Pujol-Luz; C R Rodrigues
Journal:  Cell Mol Life Sci       Date:  2004-04       Impact factor: 9.261

3.  Two purified and characterized phospholipases A2 from Cerastes cerastes venom, that inhibit cancerous cell adhesion and migration.

Authors:  Raoudha Zouari-Kessentini; José Luis; Aida Karray; Olfa Kallech-Ziri; Najet Srairi-Abid; Amine Bazaa; Erwann Loret; Sofiane Bezzine; Mohamed El Ayeb; Naziha Marrakchi
Journal:  Toxicon       Date:  2009-03-15       Impact factor: 3.033

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Isolation and biochemical characterization of a fibrinolytic proteinase from Bothrops leucurus (white-tailed jararaca) snake venom.

Authors:  C A Bello; A L N Hermogenes; A Magalhaes; S S Veiga; L H Gremski; M Richardson; Eladio F Sanchez
Journal:  Biochimie       Date:  2005-08-19       Impact factor: 4.079

6.  cDNA cloning and deduced amino acid sequence of prothrombin activator (ecarin) from Kenyan Echis carinatus venom.

Authors:  S Nishida; T Fujita; N Kohno; H Atoda; T Morita; H Takeya; I Kido; M J Paine; S Kawabata; S Iwanaga
Journal:  Biochemistry       Date:  1995-02-07       Impact factor: 3.162

7.  Coagulation factor X activating enzyme from Russell's viper venom (RVV-X). A novel metalloproteinase with disintegrin (platelet aggregation inhibitor)-like and C-type lectin-like domains.

Authors:  H Takeya; S Nishida; T Miyata; S Kawada; Y Saisaka; T Morita; S Iwanaga
Journal:  J Biol Chem       Date:  1992-07-15       Impact factor: 5.157

Review 8.  Biochemical characterization of atroxase and nucleotide sequence encoding the fibrinolytic enzyme.

Authors:  A T TU; B Baker; S Wongvibulsin; T Willis
Journal:  Toxicon       Date:  1996 Nov-Dec       Impact factor: 3.033

9.  Studies on puff adder (Bitis arietans) venom. I. Purification and properties of protease A.

Authors:  S J Van der Walt; F J Joubert
Journal:  Toxicon       Date:  1971-04       Impact factor: 3.033

10.  Factor X activator from Vipera lebetina venom is synthesized from different genes.

Authors:  Ene Siigur; Anu Aaspõllu; Katrin Trummal; Külli Tõnismägi; Indrek Tammiste; Nisse Kalkkinen; Jüri Siigur
Journal:  Biochim Biophys Acta       Date:  2004-10-01
View more
  6 in total

1.  Isolation, functional characterization and proteomic identification of CC2-PLA₂ from Cerastes cerastes venom: a basic platelet-aggregation-inhibiting factor.

Authors:  Fatah Chérifi; Abdelkader Namane; Fatima Laraba-Djebari
Journal:  Protein J       Date:  2014-02       Impact factor: 2.371

2.  Isolation and Functional Identification of an Antiplatelet RGD-Containing Disintegrin from Cerastes cerastes Venom.

Authors:  Meriem Ameziani; Fatah Chérifi; Hamida Kiheli; Samah Saoud; Ghania Hariti; Safia Kellou-Taîri; Fatima Laraba-Djebari
Journal:  Protein J       Date:  2020-09-22       Impact factor: 2.371

3.  Therapeutic Outcome of Anti-inflammatory and Antioxidative Medicines on the Dermonecrotic Activity of Cerastes cerastes Venom.

Authors:  Abderrezak Khelfi; Habiba Oussedik-Oumehdi; Fatima Laraba-Djebari
Journal:  Inflammation       Date:  2022-03-05       Impact factor: 4.092

4.  Synergistic Effect of Proteinase Activity by Purification and Identification of Toxic Protease From Nemopilema nomurai.

Authors:  Chunlin Yu; Rongfeng Li; Xiujing Yin; Huahua Yu; Pengcheng Li
Journal:  Front Pharmacol       Date:  2021-11-25       Impact factor: 5.810

Review 5.  Bioactive Molecules Derived from Snake Venoms with Therapeutic Potential for the Treatment of Thrombo-Cardiovascular Disorders Associated with COVID-19.

Authors:  Fatah Chérifi; Fatima Laraba-Djebari
Journal:  Protein J       Date:  2021-09-09       Impact factor: 2.371

6.  Isolated biomolecules of pharmacological interest in hemostasis from Cerastes cerastes venom.

Authors:  Fatah Chérifi; Fatima Laraba-Djebari
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2013-05-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.